Ketorolac Tromethamine Injection Recall: Camber
Announced 2025-10-29 · FDA
Aspiro Pharma Limited recalled Ketorolac Tromethamine Injection, USP 60 mg/2 mL due to particulate matter identified as glass. The recall covers multiple lots (AS1240347A, Exp 09/2026; AS1240144A, Exp 05/2026; AS1240145A, Exp 06/2026; AS1240146A, Exp 06/2026; AS1250295A, Exp 05/2027) and is nationwide in the United States.
| Brand | Aspiro Pharma Limited |
|---|---|
| Product | Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label). |
| Reason | Presence of Particulate Matter: Particulate matter identified as glass |
| Severity | moderate |
| Distribution | Nationwide within the United States |
| Agency | FDA |
| Recall / campaign no. | Lot #: AS1240347A, Exp Date 09/2026; AS1240144A, Exp Date 05/2026; AS1240145A, AS1240146A, Exp Date 06/2026; AS1250295A, Exp Date 05/2027. |
WHAT YOU SHOULD DO
- Do not use recalled vials.
- Check your packaging for the listed lot numbers and expiration dates.
- Contact Camber Pharmaceuticals (or your supplier) for instructions on return, replacement, or refund.
- If you have used the product or have concerns, consult your healthcare provider.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.